In Defossez P’s study, YANK2 (GSE124111, GEO Accession viewer (nih.gov)) was found to function in vivo as an activated kinase, and we further explored whether YANK2 plays a role in the glioma process. This evidence concerns the gene STK32B and central nervous system cancer.